美國BD流感試紙 美國BD品牌H7N9流感試紙試劑盒

廣州健侖生物科技有限公司

流感本公司長期供應(yīng)進口和國產(chǎn)的流感檢測試劑盒，包括臨床用和科研用的流感試劑盒，也包括金標法、酶聯(lián)免疫法和PCR熒光探針法等方法學(xué)的流感檢測試劑盒，歡迎大家。流感

楊

甲乙型流感抗原試劑盒 美國BD公司進口品牌流感檢測試劑盒

美國BD流感試紙 美國BD品牌H7N9流感試紙試劑盒

流感流行伴隨著死亡率的增加。增加的死亡率不僅僅由流感和肺炎引起，也與流感引起的心肺疾病和其他慢性病惡化有關(guān)。在美國1972－1995年的流感流行研究中，23年中有19年發(fā)生流感流行并造成超額死亡。在11次不同的流感流行中，估計每次都有2萬例與流感有關(guān)的死亡，其中6次超過4萬例。在這11次流行中，約90%以上的死亡是發(fā)生在65歲以上的老年人中。65歲以上的老年人、幼兒以及有潛在疾病的任何年齡的人群比健康的少年兒童和青年人因患流感而導(dǎo)致并發(fā)癥、住院和死亡的危險性要高。如0－4歲年齡組的住院率，健康兒童為100/10萬，而潛在疾病的兒童高達500/10萬。
有調(diào)查結(jié)果表明，法國1989年由于流感而消耗的衛(wèi)生服務(wù)費約為19億法郎，而潛在的經(jīng)濟損失更高達143億法郎;美國每年由于流感而導(dǎo)致的直接經(jīng)濟損失為10-30億美元，而潛在的經(jīng)濟損失更高達100-150億美元。中國香港地區(qū)近期爆發(fā)的流感，據(jù)估計損失也高達8000萬港幣。中國是流行感冒的高發(fā)地區(qū)，20世紀發(fā)生的4次世界性流感大流行中有3次起源于中國，近年來新發(fā)現(xiàn)的流感病毒株也大多源自中國。從1953－1976年，中國已有12次中等或中等以上的流感流行，盡管目前還缺乏詳細的流行病學(xué)資料，但可以肯定，中國每年因流行感冒而導(dǎo)致的經(jīng)濟損失也是十分驚人的。
日本在控制流感發(fā)病過程中曾采用給學(xué)齡兒童免疫接種的方法。從1962年至1987年,日本為大部分學(xué)齡兒童接種了流感疫苗,使原來過高的死亡率由zui初是美國的3～4倍降到與美國相同的水平。該免疫措施使日本每年有37000～49000人免于死亡,即每接種420名兒童就可以使1位老年人免于死亡。在美國,整個90年代流感疫苗的使用量呈穩(wěn)定增長趨勢,1997年達到每1000人中有281人使用流感疫苗的水平。同年,西歐29個國家都對流感疫苗接種作出了基于年齡的建議使用方法。老年人接種率:法國70%、比利時45%～50%、意大利36%、美國65.5%。其中許多國家通過國家財政或社會健康保險提供流感疫苗接種所需的費用,為某些建議使用疫苗的人群進行免費接種。當然,在大部分國家中,多數(shù)人還是自費支付流感疫苗所需的費用。不同國家疫苗使用水平與人均健康花費無關(guān)。疫苗使用水平反映了人們對流感的重視程度,也反映了疫苗接種的有效性。而且,預(yù)防接種是花費-收益比的預(yù)防措施。調(diào)查統(tǒng)計,美國每年因流感的直接醫(yī)療花費為46億美元,通過疫苗接種每人每年平均直接節(jié)約117美元;對于公司,投入接種疫苗1美元就可為公司節(jié)省2.58美元。阿根廷因接種計劃的實施,使每個接種兒童節(jié)約10.04美元。

美國BD流感試紙 美國BD品牌H7N9流感試紙試劑盒
The prevalence of influenza is accompanied by an increase in mortality. Increased mortality is not only caused by influenza and pneumonia, but also in relation to flu-induced cardiopulmonary disease and other chronic diseases. In the United States 1972-1995 epidemic epidemic study, 19 years, 19 years of influenza epidemic and cause excessive death. In 11 different influenza epidemics, it is estimated that every time there are 20,000 cases of influenza-related deaths, of which 6 more than 40,000 cases. In this 11 times the epidemic, about 90% of deaths occurred in the elderly over 65 years of age. People over 65 years of age, young children, and people of any age who have a potential disease are at higher risk of hospitalization and death than those of healthy children and young people who are suffering from the flu. Such as the hospitalization rate of the 0-4 age group, 100/10 million for healthy children and 500/10 million children with potential illness.
The results of the survey show that the cost of health services in France in 1989 was about 1.9 billion francs, and the potential economic losses were 14.3 billion francs; the direct economic losses caused by influenza in the United States each year were between $ 1 billion and $ 3 billion, And the potential economic losses of up to 100-150 billion US dollars. China's recent outbreak of influenza in Hong Kong, it is estimated that the loss is also up to 80 million Hong Kong dollars. China is a high incidence of influenza, the 20th century, four times the world pandemic influenza occurred in three times originated in China, in recent years, newly discovered influenza virus strains are mostly from China. From 1953 to 1976, China has 12 moderate or moderate influenza epidemics, although there is still no detailed epidemiological data, but it is certain that China's annual economic losses caused by influenza is also very alarming.
In the process of controlling the onset of influenza, Japan has adopted a method of immunization for school-age children. From 1962 to 1987, Japan vaccinated most of the school-age children with influenza vaccines, reducing the original high mortality rate from three to four times that of the United States to the same level as the United States. The immunization measures have saved 37,000 to 49,000 people in Japan each year from death, that is, every one of the 420 children can be prevented from dying. In the United States, the use of influenza vaccines throughout the 1990s showed a steady growth trend, with 1997 reaching 281 levels of influenza vaccine per 1,000 population. In the same year, 29 countries in Western Europe had made age-based recommendations for influenza vaccination. Elderly vaccination rate: France 70%, Belgium 45% to 50%, Italy 36%, the United States 65.5%. Many of these countries provide free vaccinations for certain people who use the vaccine through the cost of providing influenza vaccination through national financial or social health insurance. Of course, in most countries, most people still pay the cost of the flu vaccine at their own expense. The level of vaccine use in different countries has nothing to do with the per capita health expenditure. The level of vaccine use reflects the importance of influenza and the effectiveness of vaccination. Moreover, vaccination is cost-effective than the best precautionary measures. In the United States, the annual direct medical expenses for influenza were $ 4.6 billion, saving $ 117 per person per year by vaccination alone, and $ 1.58 for the company, which was $ 1 for vaccination. Argentina has saved $ 10,104 per child by the vaccination program.
美國BD品牌H7N9流感試紙試劑盒

我司還提供其它進口或國產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的美國BD公司產(chǎn)品及服務(wù)請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號二期2幢101-103室